Gujarat Kidney and Super Speciality will participate in the GIA Healthcare Day on August 31, 2026, engaging with investors and analysts in Mumbai. The physical group meeting is scheduled for 10:00 am to 11:00 am at the Jio World Convention Centre in BKC.

The company issued the intimation under Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. Management confirmed that discussions will rely solely on publicly available documents, with no unpublished price-sensitive information intended for release.

Meeting Details

The schedule remains indicative and subject to change due to unforeseen developments. The company noted the shorter notice period resulted from recently engaging Go India Advisors as its investor relations and public relations agency.

Dr Pragnesh Bharpoda, Managing Director, signed the disclosure filed with both the Bombay Stock Exchange and the National Stock Exchange of India. Investors interested in attending can register via the provided access link.

Gujarat Kidney and Super Speciality appointed Mrs Disha Bharpoda as an additional non-executive independent director on August 24, 2026. The appointment follows a recommendation from the Nomination and Remuneration Committee and is subject to shareholder approval at the next annual general meeting.

The Board of Directors approved the appointment during its meeting held on August 24, 2026. Mrs Bharpoda will serve a first term of five consecutive years. She is not liable to retire by rotation.

Director Profile

Mrs Bharpoda holds an MD in Radiology from Baroda Medical College, Maharaja Sayajirao University, Vadodara, completed in 2021. Her professional background includes five years as a senior resident doctor. She subsequently established her own radiology centre.

The filing confirms that Mrs Bharpoda has no relationship with any existing director of the company.

Other Board Approvals

The board also took note of the approval given by shareholders via postal ballot for a special resolution. This resolution concerns the variation in the objects or terms of utilisation of the initial public offering proceeds.

The meeting commenced at 4:30 pm and concluded at 5 pm. Pragnesh Bharpoda, managing director, signed the disclosure filed with the BSE and NSE.